Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Introduction | 6 | 1 |
| Global Markets Direct Report Coverage | 6 | 1 |
| Bronchitis Overview | 7 | 1 |
| Therapeutics Development | 8 | 1 |
| Pipeline Products for Bronchitis Overview | 8 | 1 |
| Bronchitis Therapeutics under Development by Companies | 9 | 1 |
| Bronchitis Pipeline Products Glance | 10 | 3 |
| Late Stage Products | 10 | 1 |
| Clinical Stage Products | 11 | 1 |
| Early Stage Products | 12 | 1 |
| Bronchitis Products under Development by Companies | 13 | 1 |
| Bronchitis Companies Involved in Therapeutics Development | 14 | 9 |
| AstraZeneca Plc | 14 | 1 |
| DBV Technologies S.A. | 15 | 1 |
| F. Hoffmann-La Roche Ltd. | 16 | 1 |
| Hyundai Pharmaceutical Co., Ltd. | 17 | 1 |
| Invion Limited | 18 | 1 |
| Kyorin Pharmaceutical Co., Ltd. | 19 | 1 |
| Mucosis B.V. | 20 | 1 |
| Orbis Biosciences Inc | 21 | 1 |
| Recipharm AB | 22 | 1 |
| Bronchitis Therapeutics Assessment | 23 | 9 |
| Assessment by Monotherapy Products | 23 | 1 |
| Assessment by Target | 24 | 2 |
| Assessment by Mechanism of Action | 26 | 2 |
| Assessment by Route of Administration | 28 | 2 |
| Assessment by Molecule Type | 30 | 2 |
| Drug Profiles | 32 | 18 |
| alteplase Drug Profile | 32 | 2 |
| AZD-9668 Drug Profile | 34 | 1 |
| erdosteine Drug Profile | 35 | 2 |
| HOB-051 Drug Profile | 37 | 1 |
| KRPAM-1977X Drug Profile | 38 | 2 |
| nadolol Drug Profile | 40 | 4 |
| nitric oxide Drug Profile | 44 | 2 |
| prednisone Drug Profile | 46 | 1 |
| respiratory syncytial virus vaccine Drug Profile | 47 | 1 |
| SynGEM Drug Profile | 48 | 2 |
| Bronchitis Dormant Projects | 50 | 2 |
| Bronchitis Discontinued Products | 52 | 1 |
| Bronchitis Product Development Milestones | 53 | 5 |
| Featured News &Press Releases | 53 | 1 |
| Nov 10, 2015: Recipharm secures 25 million contract for Erdosteine API with Daewoong Pharmaceutical | 53 | 1 |
| Nov 10, 2015: Recipharm secures 25 million contract for Erdosteine API with Daewoong Pharmaceutical | 53 | 1 |
| Oct 07, 2015: EVP R&D Dr Mitchell Glass discusses with BRR media data from the Phase 2 clinical trial of INV102 (nadolol) in Smoking Cessation | 54 | 1 |
| Jun 23, 2015: Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets | 54 | 1 |
| Apr 21, 2015: Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings | 55 | 1 |
| Jan 23, 2014: AIT To Present Phase II Clinical Data for NOxCureBR, A Treatment for Acute Bronchiolitis and RSV in Infants | 55 | 1 |
| Jul 22, 2013: INVION ANNOUNCES COMMENCEMENT OF PHASE II CHRONIC BRONCHITIS CLINICAL TRIAL | 56 | 1 |
| Jan 15, 2013: DBV Technologies And INRA Receive Funding To Develop Pediatric Bronchiolitis Vaccine | 56 | 2 |
| Appendix | 58 | 2 |
| Methodology | 58 | 1 |
| Coverage | 58 | 1 |
| Secondary Research | 58 | 1 |
| Primary Research | 58 | 1 |
| Expert Panel Validation | 58 | 1 |
| Contact Us | 58 | 1 |
| Disclaimer | 59 | 1 |